Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Neurology
•
Neuro-immunology
Do you consider steroid-sparing agents for treatment of patients with steroid responsive relapsed Hashimoto Encephalopathy?
Related Questions
What is the diagnostic approach and management for suspected Hashimoto Encephalitis?
What biomarkers best predict the response to B-cell depleting therapies in MS?
For stroke patients with ablated paroxysmal atrial fibrillation without known recurrence and ICAD, would you recommend dual antiplatelet therapy or anticoagulation with or without an antiplatelet agent?
When should patients be referred for advanced MRI testing to assess for CVS and PRL?
When would you use ofatumumab for anti-NMDAR autoimmune encephalitis?
What therapy do you recommend in situations where IV steroids and IVIg do not help patients with GABA-A encephalitis?
How do you decide on long term immunosuppression therapy for Susac Syndrome?
Would a longstanding diagnosis of multiple sclerosis impact your radiation recommendations for a patient with breast cancer?
How do you approach new-onset idiopathic intracranial hypertension (IIH) with someone who has history of systemic lupus erythematosus?
What strategies do you find helpful in advanced care planning with patients/families who are very "miracle" centered?
